Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Stalwart Greenwood Announces Departure

Oct 09 2019

• By Derrick Gingery

Medical engineering concept_227959225_1200.jpg — While at BIO, Jim Greenwood helped lead PDUFA negotiations and open the US market to biosimilars. • Source: Shutterstock

Related Content

House Democrats Launch Price Negotiation Push: Extreme Plan Assures Strong Opposition

Sep 20 2019

Trump Pushes Importation, Claims Success In Lowering Prices

Oct 04 2019

Advances On the Biosimilar Litigation Battlefield

Aug 19 2019

US Throws Drug Pricing Weight Around, But Still Depends On Pharma Decisions

Oct 28 2018

If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO

Jul 23 2015

GPhA After Jaeger: Will Industry Pressures Push Firms Together Or Pull Association Apart? New CEO Must Face Down FOBs

May 10 2010

PhRMA Will Pursue Future ‘Cures’ Without Castellani: CEO Retiring Jan. 1

Apr 16 2015

BIO Top Job May Go To Rep. Greenwood

Jul 20 2004

PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise

Sep 28 2015

Rep. Greenwood Will Join BIO In January

Jul 22 2004

Biosimilar Labeling Needs Greater Transparency, BIO And PhRMA Say

Jan 08 2016

Related Companies

Ovid Therapeutics, Inc.

Additional Topics

United States Leadership Pricing Debate Policy BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window